Literature DB >> 15369044

Human plague in 2002 and 2003.

.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15369044

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  25 in total

1.  Efficient tracing of global isolates of Yersinia pestis by restriction fragment length polymorphism analysis using three insertion sequences as probes.

Authors:  Gabriela Torrea; Viviane Chenal-Francisque; Alexandre Leclercq; Elisabeth Carniel
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Transmission potential of primary pneumonic plague: time inhomogeneous evaluation based on historical documents of the transmission network.

Authors:  Hiroshi Nishiura; Markus Schwehm; Masayuki Kakehashi; Martin Eichner
Journal:  J Epidemiol Community Health       Date:  2006-07       Impact factor: 3.710

3.  Ecological characteristics of flea species relate to their suitability as plague vectors.

Authors:  Boris R Krasnov; Georgy I Shenbrot; David Mouillot; Irina S Khokhlova; Robert Poulin
Journal:  Oecologia       Date:  2006-05-31       Impact factor: 3.225

4.  Draft genome sequence of Yersinia pestis strain 2501, an isolate from the great gerbil plague focus in Xinjiang, China.

Authors:  Surong Sun; Xianwei Yang; Yanting Yuan; Xiang Dai; Yanfeng Yan; Hanli Cao; Tao Luo; Rong Guo; Xinhui Wang; Yajun Song; Ruifu Yang; Yujiang Zhang; Yujun Cui
Journal:  J Bacteriol       Date:  2012-10       Impact factor: 3.490

5.  Assessing human risk of exposure to plague bacteria in northwestern Uganda based on remotely sensed predictors.

Authors:  Rebecca J Eisen; Kevin S Griffith; Jeff N Borchert; Katherine MacMillan; Titus Apangu; Nicholas Owor; Sara Acayo; Rogers Acidri; Emily Zielinski-Gutierrez; Anna M Winters; Russell E Enscore; Martin E Schriefer; Charles B Beard; Kenneth L Gage; Paul S Mead
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

6.  Structure of the Yersinia pestis FabV enoyl-ACP reductase and its interaction with two 2-pyridone inhibitors.

Authors:  Maria W Hirschbeck; Jochen Kuper; Hao Lu; Nina Liu; Carla Neckles; Sonam Shah; Steffen Wagner; Christoph A Sotriffer; Peter J Tonge; Caroline Kisker
Journal:  Structure       Date:  2012-01-11       Impact factor: 5.006

7.  A novel post-exposure medical countermeasure L-97-1 improves survival and acute lung injury following intratracheal infection with Yersinia pestis.

Authors:  Constance N Wilson; Constance O Vance; Timothy M Doyle; David S Brink; George M Matuschak; Andrew J Lechner
Journal:  Innate Immun       Date:  2011-08-23       Impact factor: 2.680

Review 8.  Plague gives surprises in the first decade of the 21st century in the United States and worldwide.

Authors:  Thomas Butler
Journal:  Am J Trop Med Hyg       Date:  2013-09-16       Impact factor: 2.345

9.  Comparison of virulence between the Yersinia pestis Microtus 201, an avirulent strain to humans, and the vaccine strain EV in rhesus macaques, Macaca mulatta.

Authors:  Guang Tian; Zhizhen Qi; Yefeng Qiu; Xiaohong Wu; Qingwen Zhang; Xiaoyan Yang; Youquan Xin; Jian He; Yujing Bi; Qiong Wang; Jiyuan Zhou; Yanxiao Fan; Yazhou Zhou; Yongqiang Jiang; Ruifu Yang; Xiaoyi Wang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

10.  Plague and the human flea, Tanzania.

Authors:  Anne Laudisoit; Herwig Leirs; Rhodes H Makundi; Stefan Van Dongen; Stephen Davis; Simon Neerinckx; Jozef Deckers; Roland Libois
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.